Latest Cancer News

Three Studies Show Revlimid Provides Benefits—and Risks—in Multiple Myeloma (05-18-2012)
Maintenance therapy with Revlimid® (lenalidomide) has been shown to significantly improve progression-free survival and time to progression in multiple myeloma, according to the results of three studies... Continue Reading

Three Studies Show Revlimid Provides Benefits—and Risks—in Multiple Myeloma (05-18-2012)
Maintenance therapy with Revlimid® (lenalidomide) has been shown to significantly improve progression-free survival and time to progression in multiple myeloma, according to the results of three studies... Continue Reading

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (05-17-2012)
Two million cancer cases each year—or roughly 16 percent of cancers worldwide—are the result of preventable and treatable infections such as human papillomavirus (HPV) and Hepatitis C (HCV), according... Continue Reading

More Cancer News

Patient Videos

01 Chemo

Click here to view

More Videos..click here

Please remember that views expressed here represent my opinion, not those of any medical clinic or hospital system. This information does not constitute medical advice and is intended to supplement but not replace medical information provided by your doctor.